Impact of hydroxychloroquine used as DMARD on SARS CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases

Publication date: Available online 26 May 2021Source: Joint Bone SpineAuthor(s): Ludovic Trefond, Elodie Drumez, Marc Andre, Nathalie Costedoat-Chalumeau, Raphaèle Seror, Mathilde Devaux, Emmanuelle Dernis, Yannick Dieudonné, Soumaya El Mahou, Aurelia Lanteri, Isabelle Melki, Viviane Queyrel, Mathilde Roumier, Jean Schmidt, Thomas Barnetche, Thierry Thomas, Patrice Cacoub, Alexandre Belot, Olivier Aumaitre, Christophe Richez
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research